Will iPS cells enhance therapeutic applicability of cord blood cells and banking?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20074533.
- Also identified by DOI 10.1016/j.stem.2009.12.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.
Medical subject headings
- Blood Banks
- Fetal Blood
- Induced Pluripotent Stem Cells